期刊文献+

工程化噬菌体在解决细菌耐受性问题中的应用策略 被引量:2

Strategies for the Application of Engineered Phages in Solving Bacterial Tolerance Problems
下载PDF
导出
摘要 细菌对抗菌药的强耐受性是临床治疗感染性疾病的一大难题,也因此受到人们的广泛关注。细菌通过多种机制获得耐药性,从而逃避抗菌类药物的杀灭。噬菌体是一类特异性侵染细菌等微生物的病毒群体,近年来其在临床上耐药菌感染性疾病治疗的应用中取得了一些成效,但随之出现的噬菌体耐受性问题使其应用受到一定的限制。该文综述了细菌耐受性,即细菌对抗菌药的耐药性和对噬菌体的耐受性的主要机制,以及当前合成生物学在解决细菌耐受抗生素和耐受天然噬菌体中的主要进展。 The development of bacterial resistance to antimicrobial drugs is a major challenge in the clinical treatment of infectious diseases and has received widespread attention.Bacteria acquire resistance through a variety of mechanisms to evade killing by antimicrobial drugs.Phage is a generic term for bacteriophage that infects microorganisms such as bacteria,fungi,actinomycetes or spirochetes.Its application in the treatment of infectious diseases with drug-resistant bacteria in clinical settings has achieved some success in recent years,but the ensuing problem of phage resistance has limited its application.This paper reviews the main mechanisms of bacterial drug resistance and phage resistance,and the main current advances in synthetic biology in addressing bacterial resistance to antibiotics and resistance to natural phages.
作者 张和 张新宇 安文林 童贻刚 ZHANG He;ZHANG Xinyu;AN Wenlin;TONG Yigang(College of Life Science and Technology,Beijing University of Chemical Technology,Beijing 100029,China)
出处 《集成技术》 2021年第4期17-32,共16页 Journal of Integration Technology
基金 国家重点研发计划项目(2018YFA0903000) 国家自然科学基金项目(81572045,81672001,81621005,31900489) 中央高校基础研究经费和中日友好医院生物医学转化研究项目(PYBZ1820) 国家科技重大专项项目(2018ZX10201001)。
关键词 合成生物学 噬菌体 耐受性 抗菌类药物 synthetic biology bacteriophage tolerance antibacterial drug
  • 相关文献

参考文献5

二级参考文献63

  • 1王大方,倪语星.头孢西丁纸片扩散法检测耐甲氧西林金黄色葡萄球菌[J].检验医学,2004,19(6):487-489. 被引量:19
  • 2朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 3Labrie S J, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol, 2010, 8(5): 317-27.
  • 4Kiljunen S, Hakala K, Pinta E, et al. Yersiniophage phiRl- 37 is a tailed bacteriophage having a 270 kb DNA genome with thymidine replaced by deoxyuridine. Microbiology, 2005, 151(Pt 12): 4093-102.
  • 5Morello E, Saussereau E, Maura D, et al. eulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One, 2011,6(2): e16963.
  • 6Capparelli R, Nocerino N, Iannaccone M, et al. Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J Infect Dis, 2010, 201(1): 52-61.
  • 7Capparelli R, Parlato M, Borriello G, et al. Experimental phage therapy against Staphylococcus aureus in mice. Antimierob Agents Chemother, 2007, 51 (8): 2765-73.
  • 8Liu J, Dehbi M, Moeck G, et al. Antimicrobial drug discovery through bacteriophage genomics. Nat Biotechnol, 2004, 22(2): 185-91.
  • 9Cello J, Paul AV, Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science, 2002, 297(5583): 1016-8.
  • 10Smith HO, Hutchison CA, 3RD, Pfannkoch C, et al. Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides. Proc Natl Acad Sci USA, 2003, 100(26): 15440-5.

共引文献108

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部